Morphological abnormalities in ticks (Acari: Ixodidae) collected from domestic animal species in Sudan.

Morphological abnormalities in ticks have rarely been reported in nature. The existing knowledge about anomalies in ticks collected in Africa is very sparse. In this paper, we describe abnormalities in Amblyomma, Hyalomma, and Rhipicephalus ticks collected from cattle, sheep, goats, camels, and horses in Kassala and North Kordofan states, Sudan, between January and August 2017. A number of 15 adult ticks displayed one or several local anomalies, such as ectromely, abnormalities of the ventral plates, and body deformities, besides newly described multiple cuticula scars. This study presents the first report of local anomalies in ticks belonging to three genera in Sudan and highlights the need to investigate the association between such morphological abnormalities and tick biology.

Crimean-Congo haemorrhagic fever virus in Hyalomma impeltatum ticks from North Kordofan, the Sudan.

An evidence for Crimean-Congo hemorrhagic fever virus (CCHFV) was found in Hyalomma impeltatum ticks collected from sheep in North Kordofan in the Sudan. Based on sequencing of the partial segment S, the detected virus belongs to lineage I with closest similarity to CCHFV strains from Senegal. So far, this lineage is unknown in the Sudan.

Histopathology of the Liver, Kidney, and Spleen of Mice Exposed to Gold Nanoparticles.

Gold nanoparticles (GNPs) are biocompatible nanomaterials that are currently researched for biomedical applications such as imaging and targeted drug delivery. In this investigation, we studied the effects of a single dose (injected on day 1) as well as a priming dose (two injections with a gap of one week) of 5 nm, 20 nm, and 50 nm diameter GNPs on the structural and biochemical changes in the liver, kidney, and spleen of mice. The results showed that small sized GNPs (5 nm) produced significant pathological changes in the liver on day 2 that gradually reduced on day 8. The medium (20 nm) and large (50 nm) sized GNPs preferentially targeted the spleen and caused significant pathological changes to the spleen architecture on day 2 that persisted on day 8 as well. There were minimal and insignificant pathological changes to the kidneys irrespective of the GNPs size. The animals that were primed with the pre-exposure of GNPs did not show any aggravation of histological changes after the second dose of the same GNPs. None of the dose regimens of the GNPs were able to significantly affect the markers of oxidative stress including glutathione (GSH) and malondialdehyde (MDA) in all of the organs that were studied. In conclusion, the size of GNPs plays an important role in their pathological effects on different organs of mice. Moreover, the primed animals become refractory to further pathological changes after the second dose of GNPs, suggesting the importance of a priming dose in medical applications of GNPs.

A priming dose protects against gold nanoparticles-induced proinflammatory cytokines mRNA expression in mice.

AIM: To study the effect of priming doses of gold nanoparticles (GNPs) on proinflammatory cytokines in different organs of mice. MATERIALS & METHODS: Mice were injected with a single or two doses (priming group) of GNPs (5, 20 and 50 nm) and sacrificed after 1 or 7 days. The mRNA expressions of IL-1ß, IL-6 and TNF-α were determined in liver, kidney and spleen. RESULTS: A single injection of 5 nm GNPs significantly increased the mRNA expressions of IL-1ß and IL-6 in liver, which were normalized on day 7. In spleen, the GNPs of all sizes significantly increased IL-1ß and IL-6 mRNA expressions on day 1 that persisted on day 7. The priming dose of GNPs protected the animals against the acute phase induction of IL-1ß and IL-6 expressions in liver and spleen. CONCLUSION: Primed animals showed protection against GNP-induced acute immune activation suggesting the importance of the priming dose in nanomedicine.

Immunohistochemical expression of COX2 and iNOS in bladder cancer and its association with urinary schistosomiasis among Sudanese patients.

AIMS: The purpose of this study was to determine if any relationship exists between expression of COX2 and iNOS markers and urinary schistosomiasis in bladder cancers. METHODOLOGY: Immunohistochemical expression of COX2 and iNOS was assessed in formalin fixed paraffin wax processed tissues obtained from 155 patients with bladder cancers (87 SCC and 68 TCC) and 39 patients with benign bladder cystitis. RESULTS: The overall immune-expressions of COX2 and iNOS were 71.6% and 57.2% respectively, of the 194 bladder lesions. A significant Positive association between COX2 or iNOS expression with bladder lesions (SCC, TCC and cystitis) was found (p.value = 0.000). COX2 and iNOS were co-expressed among 73(83.9%) of SCC, 15(22.1%) of TCC and 11(28.2%) of the cystitis group. The relationship between COX2 and iNOS immunostaining and Schistosomal ova positivity was statistically determined by P values 0.0565 and 0.1223 for Cox2 and iNOS, respectively. CONCLUSION: There are high rates of positive expression of COX2 and iNOS among Sudanese patients with Schistosomal-related bladder lesions. There might be strong association between high rates of bladder cancers and urinary Schistosomiasis in the Sudan since, the great majority of lesions were positive for COX2.